Profound Medical Corp. (PROF)

Compare

5.85

+0.03

+(0.52%)

At close: 4:00:00 PM EDT

5.88

+0.03

+(0.51%)

After hours: 4:05:09 PM EDT

Save the Date: Profound Medical to Host Investor Event at AUA 2025

TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will host a hybrid (in-person and virtual) investor event on Monday, April 28, 2025, during the American Urological Association’s (“AUA”) Annual Meeting in Las Vegas, NV, from 3:30 p.m. to 5:00 p.m. Pacific Time (6:30 p.m. to 8:00 p.m.

GlobeNewswire 7 days ago

PROF
+0.52%
Insider Spends US$144k Buying More Shares In Profound Medical

Potential Profound Medical Corp. ( TSE:PRN ) shareholders may wish to note that the Chairman of the Board & CEO, Arun...

Simply Wall St. 12 days ago

PROF
+0.52%
Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: Record Revenue and Improved ...

Profound Medical Corp (PROF) reports a 108% revenue growth and a significant reduction in net loss, while navigating challenges in site expansion and reimbursement strategies.

GuruFocus.com 25 days ago

PROF
+0.52%
Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results

TORONTO, March 06, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported unaudited financial results for the fourth quarter and full year ended December 31, 2024. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with U.

GlobeNewswire 25 days ago

PROF
+0.52%
Profound Medical (TSE:PRN) adds CA$31m to market cap in the past 7 days, though investors from five years ago are still down 39%

Profound Medical Corp. ( TSE:PRN ) shareholders should be happy to see the share price up 11% in the last week. But...

Simply Wall St. last month

PROF
+0.52%
Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow

TORONTO, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its fourth quarter and full year 2024 financial results after market close on Thursday, March 6, 2025. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business dev

GlobeNewswire last month

PROF
+0.52%
Profound Medical Corp.'s (TSE:PRN) Profit Outlook

We feel now is a pretty good time to analyse Profound Medical Corp.'s ( TSE:PRN ) business as it appears the company...

Simply Wall St. 2 months ago

PROF
+0.52%
Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th

TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that its scheduled presentation time at the 43rd Annual J.P. Morgan Healthcare Conference has been changed to 9:00 a.m. Pacific Time on Thursday, January 16, 2025. The presentation will be broadcast live and archived on t

GlobeNewswire 2 months ago

PROF
+0.52%
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

– Fourth quarter revenue growth estimated at 105% to 110% year-over-year – – Company to start reporting in accordance with U.S. GAAP and filing with the SEC on U.S. domestic forms – – Profound reminds investors that it is scheduled to present at JPM 2025 on January 16th at 11:15 a.m. PT – TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision

GlobeNewswire 2 months ago

PROF
+0.52%
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 11:15 a.m. Pacific Time in San Francisco, CA. The presentation will be

GlobeNewswire 2 months ago

PROF
+0.52%
Chairman of the Board & CEO of Profound Medical Picks Up 3.7% More Stock

Investors who take an interest in Profound Medical Corp. ( TSE:PRN ) should definitely note that the Chairman of the...

Simply Wall St. 3 months ago

PROF
+0.52%
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares

TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The underwriters elected to exercise the over-allotment option in full, resulting in an aggregate of 5,366,705 Common Shares being issued today for aggregate gross proceeds, before d

GlobeNewswire 3 months ago

PROF
+0.52%
Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

BASE SHELF PROSPECTUS IS ACCESSIBLE, AND FINAL PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced the pricing of an underwritten public offering (the “Offering”) of 4,666,700 common shares (the “Common Shares”) at a public offering price of US$7.50 per Common Share. The gross proceeds of the Offering to Profound, before de

GlobeNewswire 3 months ago

PROF
+0.52%
Profound Medical Announces Proposed Public Offering of Common Shares

BASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ AND ON EDGAR TORONTO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) today announced that it intends to offer and sell common shares (the “Common Shares”) in an underwritten public offering (the “Offering”). In addition, Profound expects to grant the underwriters of the Offering a 30-day option to purchase up to an

GlobeNewswire 3 months ago

PROF
+0.52%
Profound Medical, Siemens Healthineers enter co-sales, co-marketing agreement

Profound Medical (PROF) entered into a definitive co-sales and co-marketing agreement with Siemens Healthineers (SIEGY) pursuant to which the companies will commercialize a new MRI-guided prostate therapy solution which combines Profound’s TULSA-PRO system and consumables with Siemens Healthineers’ Magnetom Free.Max magnetic resonance scanner. Subject to the completion of the compatibility process of TULSA-PRO and Magnetom Free.Max, the companies currently expect to initiate sales of the total p

TipRanks 3 months ago

PROF
+0.52%
SIEGY

SMAWF
Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy

– Combines Profound’s TULSA-PRO® and Siemens Healthineers’ Magnetom Free.Max – – Supports the Modern Treatment Pathway that allows for more accurate and precise diagnosis, treatment, and follow-up – – Aligns well with CMS 2025 Final Rule establishing Urology APC Level 7 reimbursement for TULSA procedure at all 3 sites of service – TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that

GlobeNewswire 3 months ago

PROF
+0.52%
Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’

TULSA procedure’s unrivaled flexibility, real-world efficacy and ongoing CAPTAIN post-market study to be featured in the scientific programs at the upcoming RSNA and SUO meetingsTORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, is pleased to announce the unveiling of its third TULSA-AI®

GlobeNewswire 4 months ago

PROF
+0.52%
Profound Medical to Participate in the Stifel 2024 Healthcare Conference

TORONTO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024 at 9:45 a.m. Eastern Time in NYC. The presentation will be broadcast live and archive

GlobeNewswire 4 months ago

PROF
+0.52%
Profound Medical Third Quarter 2024 Earnings: Misses Expectations

Profound Medical ( TSE:PRN ) Third Quarter 2024 Results Key Financial Results Net loss: US$9.36m (loss widened by 68...

Simply Wall St. 4 months ago

PROF
+0.52%
Profound Medical Corp (PROF) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses

Profound Medical Corp (PROF) reports a 64% revenue increase in Q3 2024, but faces challenges with increased operating expenses and a significant net loss.

GuruFocus.com 4 months ago

PROF
+0.52%

Performance Overview

Return	PROF	S&P/TSX Composite index (^GSPTSE)
YTD	-17.02%	+1.68%
1-Year	-29.26%	+12.84%
3-Year	-34.93%	+14.03%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Profound Medical Corp. (PROF)

Save the Date: Profound Medical to Host Investor Event at AUA 2025

Insider Spends US$144k Buying More Shares In Profound Medical

Profound Medical Corp (PROF) Q4 2024 Earnings Call Highlights: Record Revenue and Improved ...

Profound Medical Announces Fourth Quarter and Full Year 2024 Financial Results

Profound Medical (TSE:PRN) adds CA$31m to market cap in the past 7 days, though investors from five years ago are still down 39%

Profound Medical to Release Fourth Quarter and Full Year 2024 Financial Results on March 6 – Conference Call to Follow

Profound Medical Corp.'s (TSE:PRN) Profit Outlook

Update: Profound Medical’s Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Chairman of the Board & CEO of Profound Medical Picks Up 3.7% More Stock

Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares

Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares

Profound Medical Announces Proposed Public Offering of Common Shares

Profound Medical, Siemens Healthineers enter co-sales, co-marketing agreement

Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy

Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant’

Profound Medical to Participate in the Stifel 2024 Healthcare Conference

Profound Medical Third Quarter 2024 Earnings: Misses Expectations

Profound Medical Corp (PROF) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses

Performance Overview